DNA

Nanopath is looking to drastically change medical diagnostics

For co-founders Amogha Tadimety and Alison Burklund, the idea of starting Nanopath, a women-focused molecular diagnostic company, came from a need to create a company focused on women’s health d

Volta Labs grabs $20 million to address a growing genomics bottleneck

Twenty years ago, getting a human genome sequenced was a billion-dollar, international project. Today, you can get your dog’s genome sequenced by the end of the month for a few bucks. It speaks to t

Ginkgo Bioworks, valued at $15B, begins trading today: Here’s how their business works

Ginkgo Bioworks, a synthetic biology company now valued at around $15 billion, begins trading on the New York Stock Exchange today. Ginkgo’s market debut is one of the largest in biotech history. It

SoftBank-backed Embark Veterinary valued at $700M after $75M Series B

Now that you have that COVID dog, Embark Veterinary wants to help him or her be in your life for a long time by offering DNA testing with the goal of increasing their lifespan.

Maryland and Montana are restricting police access to DNA databases

Maryland and Montana have become the first U.S. states to pass laws that make it tougher for law enforcement to access DNA databases. The new laws, which aim to safeguard the genetic privacy of millio

Ansa Biotechnologies wants to usher in a new era of DNA manufacturing

Daniel Arlow has spent the last eighteen years studying genomics and synthetic biology. The arc of his career has taken the first-time founder of the new startup Ansa Biotechnologies from MIT to the f

GEDmatch confirms data breach after users’ DNA profile data made available to police

GEDmatch, the DNA analysis site that police used to catch the so-called Golden State Killer, was pulled briefly offline on Sunday while its parent company investigated how its users’ DNA profile

Emerging from stealth, Octant is bringing the tools of synthetic biology to large scale drug discovery

Octant, a company backed by Andreessen Horowitz just now unveiling itself publicly to the world, is using the tools of synthetic biology to buck the latest trends in drug discovery. As the pharmaceuti

Oxford scientists develop new coronavirus test that provides results in just 30 minutes

Scientists at the University of Oxford have developed a new coronavirus test that produces results around three times faster than the current fastest testing methods, and that requires only relatively

Karius raises $165 million for its liquid biopsy technology identifying diseases with a blood draw

“What Karius is good at is identifying those novel microbes before they become an outbreak like coronavirus,” says Mickey Kertesz, a chief executive whose life sciences startup just hauled

California senator proposes tighter regulations on direct-to-consumer genetics testing companies

A state senator in California is introducing legislation designed to provide more oversight over direct-to-consumer genetic testing companies. The new regulations, introduced by Santa Ana’s Demo

Ancestry lays off 6% of staff as consumer genetic testing market continues to decline

Excitement in the consumer genetic testing market continues to show signs of slowing down. In the past two weeks, layoffs have hit two of the biggest consumer genetic testing services — 23andme and

Mammoth Biosciences adds the final piece of the CRISPR diagnostics puzzle to its toolkit

With the announcement today that Mammoth Biosciences has received the exclusive license from the University of California, Berkeley to the new CRISPR protein Cas14, the company now has the last piece

A popular genealogy website just helped solve a serial killer cold case in Oregon

On Thursday, detectives in Portland, Ore. announced that a long-cold local murder case finally came to a resolution, 40 years after the fact. In 1979, 20-year-old Anna Marie Hlavka was found dead in t

Curious 23andMe twin results show why you should take DNA testing with a grain of salt

If you’ve ever enthusiastically sent your spit off in the mail, you were probably anxious for whatever unexpected insights the current crop of DNA testing companies would send back. Did your anc

Sophia Genetics bags $77M Series E, with 850+ hospitals signed up to its ‘data-driven medicine’

Another sizeable cash injection for big data biotech: Sophia Genetics has announced a $77 million Series E funding round, bringing its total raised to $140 million since the business was founded back

As biological manufacturing moves to the mainstream, Synvitrobio rebrands and raises cash

The pace at which the scientific breakthroughs working to bend the machinery of life to the whims of manufacturing have transformed into real businesses has intensified competition in the biomanufactu

Toward transitive data privacy and securing the data you don’t share

We are spending a lot of time discussing what happens to data when you explicitly or implicitly share it. But what about data that you have never ever shared?

Ancestry answered the DNA questions 23andMe couldn’t

A really awesome thing about being black is that ancestry can be very unclear because of, you know, slavery. Enter DNA kits.

Disputed DNA analysis software’s code open for inspection after court order

If you're going to convict or acquit based on evidence provided by a piece of software, you'd better be damn sure that software is reliable. One such program, a DNA analysis tool used in over a thousa
Load More